Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Revisiting the peritoneal dialysis dose.

John Moran1, Ricardo Correa-Rotter

  • 1WellBound, Inc., Mountain View, California 94041, USA. moranj@wellbound.com

Seminars in Dialysis
|March 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

Clinical kidney journal·2026
Same author

Kidney health for all: caring for people, protecting the planet.

Kidney medicine·2026
Same author

Patient and carer treatment preferences for oral medication in chronic kidney disease: a discrete choice experiment across eight countries.

Health and quality of life outcomes·2026
Same author

Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status.

Kidney international reports·2026
Same author

Kidney Health for All: Caring for People, Protecting the Planet.

Nephrology (Carlton, Vic.)·2026
Same author

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Hypertension (Dallas, Tex. : 1979)·2026

The minimum dose for adequate peritoneal dialysis is a weekly total Kt/V of 1.7. This dose ensures sufficient clearance, with adjustments based on patient symptoms of uremia.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • Determining the optimal dose for peritoneal dialysis is crucial for patient outcomes.
  • Previous studies have investigated various dosing strategies.

Purpose of the Study:

  • To review and synthesize evidence on the minimum effective dose for peritoneal dialysis.
  • To establish a guideline for adequate dialysis clearance.

Main Methods:

  • Systematic review of two randomized controlled trials.
  • Analysis of multiple nonrandomized studies on peritoneal dialysis dosing.

Main Results:

  • Evidence supports a weekly total Kt/V of 1.7 as the minimum dose for adequate peritoneal dialysis.
  • This dose ensures sufficient solute removal.

Related Experiment Videos

Conclusions:

  • A weekly total Kt/V of 1.7 is recommended as the minimum dose.
  • Clinical monitoring for uremia and dose adjustment are essential for personalized care.